Abstract: Journal Pre-proof Clinical Characteristics and Treatment Outcomes of Mild to Moderate Covid-19 Patients in Saudi Arabia: A Single Centre Study Mohammad Albanghali, Saleh Alghamdi, Mohammed Alzahrani, Bassant Barakat, Abdul Haseeb, Jonaid Ahmad Malik, Sakeel Ahmed, Sirajudheen Anwar PII: S1876-0341(22)00034-X DOI: https://doi.org/10.1016/j.jiph.2022.02.001 Reference: JIPH1808 To appear in: Journal of Infection and Public Health Received date: 12 June 2021 Revised date: 29 January 2022 Accepted date: 1 February 2022 Please cite this article as: Mohammad Albanghali, Saleh Alghamdi, Mohammed Alzahrani, Bassant Barakat, Abdul Haseeb, Jonaid Ahmad Malik, Sakeel Ahmed and Sirajudheen Anwar, Clinical Characteristics and Treatment Outcomes of Mild to Moderate Covid-19 Patients in Saudi Arabia: A Single Centre Study, Journal of Infection and Public Health, (2021) doi:https://doi.org/10.1016/j.jiph.2022.02.001 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2021 Published by Elsevier. Clinical Characteristics and Treatment Outcomes of Mild to Moderate Covid-19 Patients in Saudi Arabia: A Single Centre Study Mohammad Albanghali1, Saleh Alghamdi2, Mohammed Alzahrani3, Bassant Barakat2, Abdul 1 Department of Public Health, Faculty of Applied Medical Sciences, Albaha University, pr Albaha, Saudi Arabia; email: mohammad.aref@bu.edu.sa 2 oo f Haseeb4, Jonaid Ahmad Malik5 , Sakeel Ahmed6 , Sirajudheen Anwar7* Department of Clinical Pharmacy, Faculty of Clinical Pharmacy, Albaha University, 3 e- Albaha, Saudi Arabia; email: bbarakat@bu.edu.sa , saleh.alghamdi@bu.edu.sa Pharmaceutical care services department, King Fahad Hospital, Albaha, Saudi Arabia; 4 Pr email: malzahrani172@moh.gov.sa Department of Clinical pharmacy, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia; email: amhaseeb@uqu.edu.sa Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education al 5 6 ur n and Research, Guwahati, India Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Mohali, India Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Jo 7 Hail, Saudi Arabia; email: si.anwar@uoh.edu.sa Running title: Clinical Outcomes in mild COVID-19 patients. * Corresponding author: Dr. Sirajudheen Anwar, Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia E-mail address: (si.anwar@uoh.edu.sa) 1 Abstract Objective: Since the severity of symptoms affects the treatment option for Coronavirus Disease 2019 (COVID-19) patients, the treatment pattern for mild to moderate non-ICU cases must be evaluated, particularly in the current scenario of mutation and variant strain for effective decision making. Methods: The objective of retrospective analysis was to assess clinical and treatment oo f outcomes in mild to moderate symptoms in non-ICU patients with COVID-19..